The Analysis of Baselake Partners, LP's Holdings & P&L


Currently, Baselake Partners, LP holds 6 types of securities in its portfolio with a total value $2.0M. In the most recent quarter, they have increased their positions in NEUP (+222.2K shares, valued at $891.1K), SYBX (+1.1M shares, valued at $638.4K), ATHA (+75.8K shares, valued at $511.6K); decreased their positions in GBIO (-350.0K shares, valued at $1.9M); initiated new positions in NEUP (+222.2K shares, valued at $891.1K), SYBX (+1.1M shares, valued at $638.4K), ATHA (+75.8K shares, valued at $511.6K); completely sold out of GBIO (previously valued at $1.9M).


1M P&L
+285.0K+5.81%
3M P&L
+492.3K+10.48%
HY P&L
+959.7K+22.69%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology4.9M
80.3%
2Drug Manufacturers - Specialty & Generic1.2M
19.7%

Top Industries by Stock Count

1Biotechnology5 stocks
83.3%
2Drug Manufacturers - Specialty & Generic1 stocks
16.7%
Stock Holdings
New
Shares222.2K
Event2025-12-31
Filed2026-02-06
New
Shares1.1M
Event2026-01-20
Filed2026-01-23
New
Shares75.8K
Event2025-12-31
Filed2026-02-06
Sold all
SharesN/A
Event2026-02-09
Filed2026-02-11
New
SharesN/A
Event2026-05-11
Filed2026-05-28
New
SharesN/A
Event2026-05-11
Filed2026-05-28

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available